Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Por um escritor misterioso
Descrição
The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.
Estimation of Activity of CD14 Biomarker in Iraqi Burn Patients
Frontiers Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective
Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures - ScienceDirect
Staphylococcus aureus Bacteremia in Adults
Timing of follow-up blood cultures for community-onset bacteremia
Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre
IJMS, Free Full-Text
School of Pharmacy and Pharmaceutical Sciences 2020-21 Annual Report by BinghamtonU - Issuu
How to investigate and manage a patient with a Staphylococcus aureus bacteraemia
Antibiotic shows efficacy against complicated Staph bacteremia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
